Altre lingue Vaxcyte, Inc.

Azioni

PCVX

US92243G1085

Tempo reale stimato Cboe BZX Altri mercati azionari 21:58:14 19/04/2024			Variaz. 5gg	Var. 1 gen.
60,88 ^USD	+0,42%		-1,89%	-3,33%

21/03	L'insider di Vaxcyte ha venduto azioni per un valore di 552.144 dollari, secondo un recente documento SEC	MT
12/03	VAXCYTE, INC. : Mizuho Securities ancora positivo	ZM

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Vaxcyte to Present at the 23rd Annual Needham Virtual Healthcare Conference	02/04
Certain Pre-Funded Warrants of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2024.	31/03
Certain Options of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2024.	31/03
Certain Common Stock of Vaxcyte, Inc. are subject to a Lock-Up Agreement Ending on 31-MAR-2024.	31/03
Vaxcyte Insider Sold Shares Worth $552,144, According to a Recent SEC Filing	21/03
Vaxcyte Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease (IPD) in Infants	04/03
Vaxcyte, Inc. Completes Enrollment of Phase 2 Study Evaluating VAX-24 for the Prevention of Invasive Pneumococcal Disease in Infants	04/03
Vaxcyte Q4 Loss Widens	27/02
Vaxcyte, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	27/02
Vaxcyte Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update	27/02
Vaxcyte to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024	15/02
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	03/02
Vaxcyte Announces Closing of $862.5 Million Public Offering Including Full Exercise of Underwriters’ Option to Purchase Additional Shares	03/02
Vaxcyte Insider Sold Shares Worth $357,500, According to a Recent SEC Filing	02/02
Vaxcyte to Present at the Guggenheim Healthcare Talks \| 6th Annual Biotechnology Conference	01/02
Vaxcyte Insider Sold Shares Worth $1,980,900, According to a Recent SEC Filing	31/01
Vaxcyte Insider Sold Shares Worth $270,000, According to a Recent SEC Filing	31/01
Vaxcyte Prices $750 Million Public Offering at $64 Per Share	31/01
Vaxcyte Announces Pricing of $750 Million Public Offering	31/01
Vaxcyte Launches Securities Offering; Shares Fall After Hours	30/01

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Vaxcyte, Inc.

Azioni

PCVX

US92243G1085

Altre lingue

Filtri